Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: Insights from experimental models
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: Heart diseases have been a major cause of death worldwide, including developed countries. Indeed, loss of non-regenerative, terminally differentiated cardiomyocytes (CMs) due to aging or diseases is irreversible. Current therapeutic regimes are palliative in nature, and in the case of end-stage heart failure, transplantation remains the last resort. However, this option is significantly hampered by a severe shortage of donor cells and organs. Human embryonic stem cells (hESCs) can self-renew while maintaining their pluripotency to differentiate into all cell types. More recently, direct reprogramming of adult somatic cells to become pluripotent hES-like cells (a.k.a. induced pluripotent stem cells or iPSCs) has been achieved. The availability of hESCs and iPSCs, and their successful differentiation into genuine human heart cells have enabled researchers to gain novel insights into the early development of the human heart as well as to pursue the revolutionary paradigm of heart regeneration. Here we review our current knowledge of hESC-/iPSC-derived CMs in the context of two fundamental operating principles of CMs (i.e. electrophysiology and Ca2+-handling), the resultant limitations and potential solutions in relation to their translation into clinical (bioartificial pacemaker, myocardial repair) and other applications (e.g. as models for human heart disease and cardiotoxicity screening).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389 · cited 1×
“As an example, specification of human tripotent KDRlow/c-kitneg cardiovascular progenitors (CP) into CMs has been reported (19).”
BackgroundHe, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800
The sinoatrial node, a heterogeneous pacemaker structure
Boyett, M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00135-8 · Cited by 698
Xue, T., Cho, H. C., Akar, F. G., Tsang, S.-Y., Jones, S. P., Marbán, E., Tomaselli, G. F., & Li, R. A. (2005) · Circulation · doi:10.1161/01.cir.0000151313.18547.a2 · Cited by 480 · cited 1×
“Alternatively, pluripotent human embryonic stem cells (hESCs) can be differentiated into pacemaker-like derivatives for transplantation to recreate an in vivo pacemaker (8, 66).”
BackgroundSelf-citationLiu, J., Fu, J. D., Siu, C. W., & Li, R. A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0549 · Cited by 186 · cited 3×
“nodine significantly reduced the electrically-evoked Ca2+ transient amplitudes and slowed the upstroke of caffeine-responsive HES2– and H1-CMs but NOT caffeine-insensitive cells; thapsigargin, a SERCA inhibitor, similarly reduced the amplitude and slowed the decay of only caffeine-responsive HES2– and H1-CMs (31).”
BackgroundResultInfluentialSelf-citationLieu, D. K., Liu, J., Siu, C.-W., McNerney, G. P., Tse, H.-F., Abu-Khalil, A., Huser, T., & Li, R. A. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0052 · Cited by 160 · cited 2×
“Furthermore, hESC-CMs do not display t-tubules that are seen in normal adult human atrial and ventricular CMs (33) ( Fig.”
BackgroundSelf-citation
Cited by
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
“expression of cardiac markers and electrophysiological properties that confirmed their functionality, as previously shown in hESCand hiPSC-derived cardiomyocytes.(31) Nevertheless, diseasespecific properties emerged in the LQT2–hiPSC myocytes, including prolongation of the FPD/APD in beating clusters as well as in atr…”
Keung, W., Boheler, K. R., & Li, R. A. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt406 · Cited by 87
Self-citationCalcium signalling of human pluripotent stem cell-derived cardiomyocytes
Li, S., Chen, G., & Li, R. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256495 · Cited by 76
“…and non-cardiac lineages, as well as embryonic and adult stem cell populations, have been investigated as potential sources, with their pros and cons extensively reviewed elsewhere (Menasche et al. 2003; Smits et al. 2003; Murry et al. 2004; Sil et al. 2004; Kong et al. 2010; Poon et al. 2011).”
BackgroundSelf-citationWang, J., Chen, A., Lieu, D. K., Karakikes, I., Chen, G., Keung, W., Chan, C. W., Hajjar, R. J., Costa, K. D., Khine, M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.039 · Cited by 69
Self-citationChen, G., Li, S., Karakikes, I., Ren, L., Zi-Ying Chow, M., Chopra, A., Keung, W., Yan, B., Chan, C. W. Y., Costa, K. D., et al. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002049 · Cited by 38
Self-citation
Metadata
- Authors
- Kong, C.-W., Akar, F., & Li, R.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2010
- Volume
- 104
- Issue
- 07
- Pages
- 30-38
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1967379086
- Cited by
- 62
- References
- 6
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: Insights from experimental models. https://app.cochat.ai/papers/10.1160/th10-03-0189
- The paper
- Kong, C.-W., Akar, F., & Li, R. (2010). Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: Insights from experimental models. Thrombosis and Haemostasis. https://doi.org/10.1160/th10-03-0189
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.